Search

Bijan Ahvazi

Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )

Most Active Art Unit
1763
Art Unit(s)
1763, 4171, 1761, 1796
Total Applications
1549
Issued Applications
974
Pending Applications
113
Abandoned Applications
482

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9042486 [patent_doc_number] => 20130245124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'PRESERVATIVE FREE BIMATOPROST SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/812594 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1006 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812594 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/812594
PRESERVATIVE FREE BIMATOPROST SOLUTIONS Jul 27, 2011 Abandoned
Array ( [id] => 9094921 [patent_doc_number] => 20130274232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 13/810656 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8169 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810656 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/810656
Pharmaceutical Compositions Jul 17, 2011 Abandoned
Array ( [id] => 8940481 [patent_doc_number] => 20130190278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 13/813006 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9922 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813006 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/813006
Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases Jul 7, 2011 Abandoned
Array ( [id] => 8227186 [patent_doc_number] => 20120141391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Use of creatine or creatine compounds for skin preservation' [patent_app_type] => utility [patent_app_number] => 13/135254 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13860 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135254 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/135254
Use of creatine or creatine compounds for skin preservation Jun 28, 2011 Abandoned
Array ( [id] => 8964223 [patent_doc_number] => 20130203825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'PHOSPHATE-FREE HIGHLY CONCENTRATED AQUEOUS DISPERSION COMPOSITION OF BIOCIDES AND PROCESS FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/700552 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6626 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700552 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/700552
PHOSPHATE-FREE HIGHLY CONCENTRATED AQUEOUS DISPERSION COMPOSITION OF BIOCIDES AND PROCESS FOR PREPARING THE SAME May 25, 2011 Abandoned
Array ( [id] => 7490229 [patent_doc_number] => 20110237548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME USING OMEGA CHOLINE' [patent_app_type] => utility [patent_app_number] => 13/114094 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14693 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237548.pdf [firstpage_image] =>[orig_patent_app_number] => 13114094 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/114094
SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME USING OMEGA CHOLINE May 23, 2011 Abandoned
Array ( [id] => 7568038 [patent_doc_number] => 20110288101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/112827 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2452 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288101.pdf [firstpage_image] =>[orig_patent_app_number] => 13112827 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112827
SURGICAL COMPOSITIONS CONTAINING SIGMA-RECEPTOR AGONISTS May 19, 2011 Abandoned
Array ( [id] => 15513153 [patent_doc_number] => 10563153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 13/112624 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13021 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112624 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112624
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof May 19, 2011 Issued
Array ( [id] => 7586253 [patent_doc_number] => 20110280763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'LIGHT-ACTIVATED DISINFECTION SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/109238 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5487 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280763.pdf [firstpage_image] =>[orig_patent_app_number] => 13109238 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/109238
LIGHT-ACTIVATED DISINFECTION SYSTEM May 16, 2011 Abandoned
Array ( [id] => 9082061 [patent_doc_number] => 20130267591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'NOVEL OPHTHALMIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/696685 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696685 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/696685
NOVEL OPHTHALMIC COMPOSITIONS May 5, 2011 Abandoned
Array ( [id] => 7574151 [patent_doc_number] => 20110269807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'NOVEL TREATMENT FOR AGE RELATED MACULAR DEGENERATION AND OCULAR ISCHEMIC DISEASE ASSOCIATED WITH COMPLEMENT ACTIVATION BY TARGETING 5-LIPOXYGENASE' [patent_app_type] => utility [patent_app_number] => 13/098200 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6754 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269807.pdf [firstpage_image] =>[orig_patent_app_number] => 13098200 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098200
NOVEL TREATMENT FOR AGE RELATED MACULAR DEGENERATION AND OCULAR ISCHEMIC DISEASE ASSOCIATED WITH COMPLEMENT ACTIVATION BY TARGETING 5-LIPOXYGENASE Apr 28, 2011 Abandoned
Array ( [id] => 8792790 [patent_doc_number] => 20130109759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'FORMULATIONS OF QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/643542 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24234 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643542 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/643542
FORMULATIONS OF QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES Apr 25, 2011 Abandoned
Array ( [id] => 8685070 [patent_doc_number] => 20130053354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/643803 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3951 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643803 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/643803
Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative Apr 24, 2011 Issued
Array ( [id] => 9042450 [patent_doc_number] => 20130245088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/640033 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7020 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640033 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/640033
KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING Apr 5, 2011 Abandoned
Array ( [id] => 7488165 [patent_doc_number] => 20110251285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'COMBINATIONS OF PRESERVATIVES FOR OPHTHALMIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/081318 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5458 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251285.pdf [firstpage_image] =>[orig_patent_app_number] => 13081318 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/081318
COMBINATIONS OF PRESERVATIVES FOR OPHTHALMIC COMPOSITIONS Apr 5, 2011 Abandoned
Array ( [id] => 8066055 [patent_doc_number] => 20110243999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/079688 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14077 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243999.pdf [firstpage_image] =>[orig_patent_app_number] => 13079688 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/079688
METHODS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS Apr 3, 2011 Abandoned
Array ( [id] => 8417696 [patent_doc_number] => 20120245197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING TOSUFLOXACIN OR SALT THEREOF' [patent_app_type] => utility [patent_app_number] => 13/053515 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1863 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13053515 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/053515
PHARMACEUTICAL COMPOSITION CONTAINING TOSUFLOXACIN OR SALT THEREOF Mar 21, 2011 Abandoned
Array ( [id] => 6163074 [patent_doc_number] => 20110160172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/043118 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4717 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160172.pdf [firstpage_image] =>[orig_patent_app_number] => 13043118 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/043118
FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS Mar 7, 2011 Abandoned
Array ( [id] => 6163230 [patent_doc_number] => 20110160210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'CONTROL OF INTRAOCULAR PRESSURE USING ALK5 MODULATION AGENTS' [patent_app_type] => utility [patent_app_number] => 13/042848 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5031 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160210.pdf [firstpage_image] =>[orig_patent_app_number] => 13042848 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/042848
CONTROL OF INTRAOCULAR PRESSURE USING ALK5 MODULATION AGENTS Mar 7, 2011 Abandoned
Array ( [id] => 6087777 [patent_doc_number] => 20110217262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability' [patent_app_type] => utility [patent_app_number] => 13/042437 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4530 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217262.pdf [firstpage_image] =>[orig_patent_app_number] => 13042437 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/042437
Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability Mar 6, 2011 Abandoned
Menu